ES2070151T3 - Agentes cardiotonicos. - Google Patents

Agentes cardiotonicos.

Info

Publication number
ES2070151T3
ES2070151T3 ES89114712T ES89114712T ES2070151T3 ES 2070151 T3 ES2070151 T3 ES 2070151T3 ES 89114712 T ES89114712 T ES 89114712T ES 89114712 T ES89114712 T ES 89114712T ES 2070151 T3 ES2070151 T3 ES 2070151T3
Authority
ES
Spain
Prior art keywords
optionally
phenyl
ring
substituents
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89114712T
Other languages
English (en)
Inventor
Takafumi Fujioka
Shuji Teramoto
Michiaki Tominaga
Yoichi Yabuuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2070151T3 publication Critical patent/ES2070151T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

AGENTE PARA PROFILAXIS Y TRATAMIENTO DE ENFERMEDADES DEL CORAZON USANDO UN DERIVADO DE CARBOESTIRILO DE FORMULA: EN DONDE R1 ES H O CN, Y R (AL CUADRADO) Y R3 SON CADA UNO H, ALQUILO OPCIONALMENTE SUBSTITUIDO POR OH, CICLOALQUILO, ALQUENILO, FENILO, FENILALQUILO TENIENDO OPCIONALMENTE SUBSTITUYENTES DE ALCOXIALCOXI, HALOGENO, ALCOXI, NO2, ALQUILO, CN, ALQUILTIO O ALQUILSULFINILO SOBRE ANILLO FENILO Y TENIENDO OPCIONALMENTE SUBSTITUYENTES OH SOBRE LA MITAD DEL ALQUILO, FENILSULFONIALQUILO TENIENDO OPCIONALMENTE SUBSTITUYENTE ALCOXILO SOBRE EL ANILLO FENILO, FENILTIOALQUILO, FENILSULFINILOALQUILO TENIENDO OPCIONALMENTE SUBSTITUYENTES DE HALOGENO O ALCOXILO SOBRE ANILLO FENILO, FENOXIALQUILO TENIENDO OPCIONALMENTE SUBSTITUYENTES DE HALOGENO O ALCOXILO SOBRE ANILLO FENILO, PIRIDILO ALQUILO TENIENDO OPCIONALMENTE SUBSTITUYENTES DE HALOGENO O ALCOXILO SOBRE EL ANILLO DE PIRIDINA, TIENILALQUILO, BENZOILALQUILO, ANILINOTIOCARBONILO, BENZOILO, PIRIDILO, FENILALQUENILO, O GRUPO DE -A-NR4R5(R4 Y R5SON CADA UNO ALQUILO O FENILO TENIENDO OPCIONALMENTE SUBSTITUYENTES DE HALOGENO O ALCOXILO SOBRE EL ANILLO FENILO, Y A ES ALQUILENO, EL CUAL PUEDE ESTAR INTERRUMPIDO CON O), Y UNA SAL DE ELLOS Y NUEVOS DERIVADOS DE CARBOESTIRILO, Y COMPOSICION FARMACEUTICA PARA LA PROFILAXIS Y TRATAMIENTO DE ENFERMEDADES DEL CORAZON, CONTENIENDO DICHOS NUEVOS DERIVADOS DE CARBOESTIRILO.
ES89114712T 1988-08-10 1989-08-09 Agentes cardiotonicos. Expired - Lifetime ES2070151T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP20092988 1988-08-10
JP3468889 1989-02-14
JP16017089 1989-06-21

Publications (1)

Publication Number Publication Date
ES2070151T3 true ES2070151T3 (es) 1995-06-01

Family

ID=27288505

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89114712T Expired - Lifetime ES2070151T3 (es) 1988-08-10 1989-08-09 Agentes cardiotonicos.

Country Status (7)

Country Link
US (2) US5053514A (es)
EP (1) EP0355583B1 (es)
JP (1) JP2648970B2 (es)
KR (1) KR0139626B1 (es)
DE (1) DE68920797T2 (es)
DK (1) DK391189A (es)
ES (1) ES2070151T3 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198448A (en) * 1988-08-10 1993-03-30 Otsuka Pharmaceutical Company, Limited Cardiotonics
US5082847A (en) * 1990-07-18 1992-01-21 Syntex (U.S.A.) Inc. Carbostyril compounds connected via an oxyalkyl group with a piperidine ring and having pharmaceutical utility
TW201305B (es) * 1991-04-03 1993-03-01 Otsuka Pharma Co Ltd
EP0569592A4 (en) * 1991-08-23 1994-12-07 Otsuka Pharma Co Ltd CARBOSTYRILE DERIVATIVE AND PLATELET ANTIAGGREGATOR.
JPH06183976A (ja) * 1992-09-18 1994-07-05 Otsuka Pharmaceut Co Ltd 抗不整脈剤
DE69316018T2 (de) * 1992-09-18 1998-04-16 Otsuka Pharma Co Ltd Carbostyrilderivate als antiarrhytmika
TW254855B (es) * 1993-07-28 1995-08-21 Otsuka Pharma Co Ltd
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
KR19980701286A (ko) * 1995-01-09 1998-05-15 오스카 아키히코 Tnf-알파 억제제
EP0901459B1 (en) 1996-04-09 2005-06-29 Nps Pharmaceuticals, Inc. Calcilytic compounds
US6818660B2 (en) 1996-04-09 2004-11-16 Nps Pharmaceuticals, Inc. Calcilytic compounds
US7202261B2 (en) 1996-12-03 2007-04-10 Nps Pharmaceuticals, Inc. Calcilytic compounds
TW483881B (en) 1996-12-03 2002-04-21 Nps Pharma Inc Calcilytic compounds
NZ503044A (en) * 1997-09-24 2001-08-31 Orion Corp Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors
HU227441B1 (en) † 1997-11-24 2011-06-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Process for producing carvedilol, enantiomers and salts thereof
US7053092B2 (en) 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
US8703772B2 (en) 2001-09-25 2014-04-22 Otsuka Pharmaceutical Co., Ltd. Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
US20070060748A1 (en) * 2002-11-27 2007-03-15 Hamilton Gregory S Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure
WO2004058726A2 (en) * 2002-12-23 2004-07-15 Artesian Therapeutics, Inc. CARDIOTONIC COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST β-ADRENERGIC RECEPTORS AND PHOSPHODIESTERASE
TWI481601B (zh) * 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd 含氮化合物及藥學組成物
KR102015054B1 (ko) * 2015-08-10 2019-08-27 동우 화인켐 주식회사 네가티브형 감광성 수지 조성물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1058822A (en) * 1963-07-30 1967-02-15 Ici Ltd 3-amino-2-hydroxypropoxy heterocyclic derivatives
JPS48103590A (es) * 1972-04-13 1973-12-25
JPS4951271A (es) * 1972-09-28 1974-05-18
JPS5241270B2 (es) * 1973-01-25 1977-10-17
JPS5082218A (es) * 1973-11-10 1975-07-03
JPS539227B2 (es) * 1973-12-26 1978-04-04
US4210753A (en) * 1976-03-17 1980-07-01 Otsuka Pharmaceutical Co., Ltd. Carbostyril compounds
DE2805404A1 (de) * 1978-02-09 1979-08-16 Merck Patent Gmbh 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung
JPS54151985A (en) * 1978-05-17 1979-11-29 Otsuka Pharmaceut Co Ltd Preparation of aminocarbostyril derivative
AU518814B2 (en) * 1979-01-30 1981-10-22 Otsuka Pharamaceutical Co. Glaucoma treatment
DD150456A5 (de) * 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
JPS55129268A (en) * 1979-03-28 1980-10-06 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS5695115A (en) * 1979-12-28 1981-08-01 Otsuka Pharmaceut Co Ltd Remedy for glaucoma
JPS568319A (en) * 1980-03-26 1981-01-28 Otsuka Pharmaceut Co Ltd Antihistamine
JPS5780322A (en) * 1980-11-05 1982-05-19 Otsuka Pharmaceut Co Ltd Cardiotonic agent
DE3330005A1 (de) * 1983-08-19 1985-02-28 Wolfgang Dr. Graz Lindner Weinsaeuremonoester von optisch aktiven alkanolaminen, verfahren zu ihrer herstellung und ihre verwendung
GB2163150B (en) * 1984-07-19 1988-05-25 Sandoz Ltd 3-aminopropoxyaryl derivatives
DK397387A (da) * 1986-07-31 1988-02-01 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser

Also Published As

Publication number Publication date
DK391189D0 (da) 1989-08-09
KR900003127A (ko) 1990-03-23
US5385914A (en) 1995-01-31
KR0139626B1 (ko) 1998-06-01
JPH0386864A (ja) 1991-04-11
EP0355583A2 (en) 1990-02-28
EP0355583B1 (en) 1995-01-25
DE68920797D1 (de) 1995-03-09
JP2648970B2 (ja) 1997-09-03
DK391189A (da) 1990-02-11
EP0355583A3 (en) 1991-11-06
DE68920797T2 (de) 1995-06-29
US5053514A (en) 1991-10-01

Similar Documents

Publication Publication Date Title
ES2070151T3 (es) Agentes cardiotonicos.
NO2017067I1 (no) Everolimus - forlenget SPC
KR930702292A (ko) 종양 치료 활성을 증대시키기 위한 퀴나졸린 유도체
NO995245D0 (no) Anvendelse av tetrahydropyridinderivater for fremstilling av medisiner for Õ behandle sykdommer som bevirker demyelinisering
AR019167A1 (es) Derivados heteroaromaticos de piperazinas di-n-sustituidas y piperidinas 1,4-disustituidas, composiciones farmaceuticas y el uso de los mismos para lapreparacion de medicamentos
DE3685823D1 (de) Sulfamoyl-harnstoff-derivate.
ES2130506T3 (es) Uso de 5-acil-1,4-dihidropiridinas para tratamiento de enfermedades del snc.
AR012730A1 (es) Compuestos derivados de aminocicloalquilpirrolidina sustituida cis-sustituidos, droga, agente antimicrobiano y compuesto intermediario
MY101864A (en) Barbituric acid derivatives
RU2000114807A (ru) Пиперазин-циклодекстриновый комплекс
FI950403A0 (fi) Neurosuojaavia yhdisteitä
IT1155358B (it) Derivati chinazolinonici attivi contro la coccidiosi
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
ES380026A2 (es) Produccion de 4 - fenilimino-i,4-dihidroquinolinas.
ES397787A1 (es) Procedimiento para la obtencion de derivados del indol con propiedades farmaceuticas.
ES2151828B1 (es) Empleo de derivados de tetrahidropiridinas (ohidroxi-piperidinas)-b utilazoles en la elaboracion de un medicamento para el tratamiento del dolor.
HU912140D0 (en) Fungicide preparations containing benzyl-ketones and process for the production of the active agents
FR2655042B1 (fr) Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
IT1187678B (it) Procedimento di preparazione di derivati eterociclici
ATE62904T1 (de) Phenyl- und heterocyclische tetrahydropyridylund piperazinyl-alkoxy-benzheterocyclische verbindungen als antipsychotische heilmittel.
FR2060444A5 (en) Benzimidazolyl carbamic esters
AR009555A1 (es) Derivados de n-bencilazolilo, su empleo, un metodo para la terapia de infecciones fungicas por medio de ellos, procedimientos para elaborarlos ycomposiciones antifungicas que los comprenden
RU92004439A (ru) Азотсодержащие тетрациклические соединения, способ их получения, применение и фармацевтическая композиция
RU2004114244A (ru) Ацилсульфонамиды в качестве ингибиторов стероидсульфатазы
NL7407218A (en) 4-(3-Amino-2-acyloxypropoxyl)-1,2,5-thiadiazoles - useful as beta-adrenergic blocking agents

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 355583

Country of ref document: ES